🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 03753U106
- Market Cap
- Large Cap
- IPO
- $14.00/share
Business: Apellis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds to treat disease through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.
Company Contact
- CEO
- Cedric Francois, M.D., Ph.D.
- CFO
- Timothy Sullivan
- Headquarters
- 100 Fifth Avenue, Waltham, MA 02451
- Phone
- 502-241-4114
- Investor Relations
- Meredith Kaya · 617-599-8178 · meredith.kaya@apellis.com